LL‑37 (Cathelicidin Antimicrobial Peptide)
LL‑37 is a human‑derived, 37‑amino‑acid antimicrobial peptide produced as part of the innate immune system. It has gained significant attention in dermatology, immunology, and regenerative research for its ability to modulate inflammation, support tissue repair, and maintain a balanced skin microbiome.
Key Benefits
Microbiome Defense: Acts as a broad‑spectrum antimicrobial peptide, supporting the skin’s natural defense against bacteria, biofilms, and environmental stressors.
Inflammation Modulation: Helps regulate inflammatory signaling pathways, contributing to reduced redness, irritation, and visible reactivity.
Tissue Repair Support: Promotes cellular migration and wound‑healing processes, making it a focus of research in skin regeneration and barrier recovery.
Barrier Optimization: Supports the integrity of the skin barrier, encouraging smoother texture, improved clarity, and enhanced resilience.
🔬 Research Use Only
This product is intended for Research purposes only.